Excellgene Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 3

Excellgene General Information

Description

Operator of a biologic contract development and manufacturing organization (CDMO) specializing in challenging protein expression services based in Monthey, Switzerland. The company's platfrom specializes in protein expression technologies as well as the creation of stable, high-yielding community health officer and HEK cell lines and processes, it has extended expertise in manufacturing processes and technology transfer, and its products are cultivated in animal cells and simple antibodies through clone screening to identify the optimal match of physiology and genetics for the highest yield, enabling the biopharma industry to scale up transient gene expression in non-instrumented bioreactors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
BPO/Outsource Services
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • Route de l'Ile-au-Bois 1A
  • 1870 Monthey
  • Switzerland
+41 024 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Excellgene Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Excellgene‘s full profile, request access.

Request a free trial

Excellgene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biologic contract development and manufacturing organization (CDMO) specializing in challenging protein ex
BPO/Outsource Services
Monthey, Switzerland
60 As of 2023
0000000 0000

0000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur
0000000000000
Newark, CA
000 As of 0000
0000000000

000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim venia
00000 0000000000 000
Boston, MA
00 As of 0000
00000
00.000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Excellgene Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ATUM Corporation Newark, CA 000 0000000000
Asimov Venture Capital-Backed Boston, MA 00 00000 00000000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Excellgene Patents

Excellgene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3924463-A1 Novel eukaryotic cell transfection systems and related methods Pending 11-Feb-2019 000000000
EP-3914614-A1 Methods of producing and using recombinant alpha 1-antitrypsin (aat) and compositions thereof Pending 24-Jan-2019 00000000000
AU-2020211080-A1 Methods of producing and using recombinant alpha 1-antitrypsin (aat) and compositions thereof Pending 24-Jan-2019 00000000000
US-20220112270-A1 Methods of producing and using recombinant alpha 1-antitrypsin (aat) and compositions thereof Pending 24-Jan-2019 00000000000 0
CA-3127750-A1 Methods of producing and using recombinant alpha 1-antitrypsin (aat) and compositions thereof Pending 24-Jan-2019 C07K14/8125
To view Excellgene’s complete patent history, request access »

Excellgene Executive Team (6)

Name Title Board Seat Contact Info
Maria Wurm Co-Founder, Chief Executive Officer & Board Member
Divor Kiseljak Chief Operations Officer
Sebastian Rheindorf-Zaorski Chief Strategy Officer & Board Member
Florian Wurm Ph.D Co-Founder, Chief Scientific Officer & Chairman
Martin Schmid Chief Financial Officer & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Excellgene Board Members (6)

Name Representing Role Since
0000000 0000 00.0 Excellgene Co-Founder, Chief Scientific Officer & Chairman 000 0000
00000 0000000000 Self Non-Executive Board Member 000 0000
000 0000000000 Self Non-Executive Board Member 000 0000
00000 0000 Excellgene Co-Founder, Chief Executive Officer & Board Member 000 0000
000000 000000 Self Chief Financial Officer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Excellgene Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Excellgene Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Excellgene‘s full profile, request access.

Request a free trial

Excellgene FAQs

  • When was Excellgene founded?

    Excellgene was founded in 2001.

  • Who is the founder of Excellgene?

    Maria Wurm and Florian Wurm Ph.D are the founders of Excellgene.

  • Who is the CEO of Excellgene?

    Maria Wurm is the CEO of Excellgene.

  • Where is Excellgene headquartered?

    Excellgene is headquartered in Monthey, Switzerland.

  • What is the size of Excellgene?

    Excellgene has 60 total employees.

  • What industry is Excellgene in?

    Excellgene’s primary industry is BPO/Outsource Services.

  • Is Excellgene a private or public company?

    Excellgene is a Private company.

  • What is Excellgene’s current revenue?

    The current revenue for Excellgene is 000000.

  • Who are Excellgene’s investors?

    Kulczyk Investments has invested in Excellgene.

  • Who are Excellgene’s competitors?

    ATUM and Asimov are competitors of Excellgene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »